Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Aug 6, 2026 | $1.37 | +328.1% | $801.70M | +23.5% | $1.46 |
| Q1 FY26ended Mar 31, 2026 | May 14, 2026 | $1.30 | +160.0% | $761.70M | +33.9% | $1.20 |
| Q4 FY25ended Dec 31, 2025 | — | $1.41 | +3.7% | $783.80M | +31.2% | — |
| Q3 FY25ended Sep 30, 2025 | — | $1.24 | +14.8% | $706.30M | +29.9% | — |
| Q2 FY25ended Jun 30, 2025 | — | $0.32 | −87.6% | $649.10M | +32.9% | — |
| Q1 FY25ended Mar 31, 2025 | — | $0.50 | −31.5% | $569.00M | +28.8% | — |
| Q4 FY24ended Dec 31, 2024 | — | $1.36 | +6.3% | $597.50M | +17.2% | — |
| Q3 FY24ended Sep 30, 2024 | — | $1.08 | +45.9% | $543.90M |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Insulet shares, not any token. As of Aug 6, 2026, from Massive's standardised financials and the earnings calendar.
| +25.7% |
| — |
| Q2 FY24ended Jun 30, 2024 | — | $2.59 | — | $488.50M | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $0.73 | — | $441.70M | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $1.28 | — | $509.80M | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $0.74 | — | $432.70M | — | — |